City Insurance PLC. announcements
354 Dhaka Stock Exchange announcements for City Insurance PLC. (CITYGENINS) since 2008: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (23).
- Credit Rating Information and Services Limited (CRISL) has assigned the CPA (Claim Paying Ability) Rating of the Company
Credit Rating Information and Services Limited (CRISL) has assigned the CPA (Claim Paying Ability) Rating of the Company \"AA+\" in the long term along with stable outlook in consideration of audited financials of the Company up to December 31, 2021; unaudited financial up to September 30, 2022 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- (Continuation news of CITYGENINS): because the company\'s premium income increased significantly. NAVPS has been increas
(Continuation news of CITYGENINS): because the company\'s premium income increased significantly. NAVPS has been increased for the period from 01 January 2022 to 30 September 2022 (Un-audited) in comparison to the same period of the previous year 2021 because the company\'s investments in Govt. Treasury bond and FDR have been increased notably. (end)
The first part of this announcement is missing from the archive. - (Continuation news of CITYGENINS): The Company has also informed that EPS has been increased for the period from 01 Janu
(Continuation news of CITYGENINS): The Company has also informed that EPS has been increased for the period from 01 January 2022 to 30 September 2022 (Un-audited) in comparison to the same period of the previous year 2021 because of premium income increased sharply. NOCFPS has been increased for the period from 01 January 2022 to 30 September 2022 (Un-audited) in comparison to the same period of the previous year 2021 (Cont.2)
The first part of this announcement is missing from the archive. - Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.57 for July-September 2022 as against Tk. 0.47 for July-September 2021; EPS was Tk. 1.61 for January-September 2022 as against Tk. 1.28 for January-September 2021. NOCFPS was Tk. 4.28 for January-September 2022 as against Tk. 1.95 for January-September 2021. NAV per share was Tk. 19.15 as on September 30, 2022 and Tk. 17.53 as on December 31, 2021. (Cont.1)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2022.
- (Q2 Un-audited): EPS was Tk. 0.65 for April-June 2022 as against Tk. 0.31 for April-June 2021; EPS was Tk. 1.04 for Janu
(Q2 Un-audited): EPS was Tk. 0.65 for April-June 2022 as against Tk. 0.31 for April-June 2021; EPS was Tk. 1.04 for January-June 2022 as against Tk. 0.81 for January-June 2021. NOCFPS was Tk. 3.34 for January-June 2022 as against Tk. 1.58 for January-June 2021. NAV per share was Tk.18.28 as on June 30, 2022 and Tk. 17.53 as on December 31, 2021. (cont.)
- Q2 Financials
(Continuation news of CITYGENINS): The Company has informed that EPS and NOCFPS have increased due to sharp increase of premium income. NAV has increased due to increase of investment in Govt. Treasury bond and FDR. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 28, 2022 at 8:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2022.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended December 31, 2021 to the respective shareholders.
- (Q1 Un-audited): EPS was Tk. 0.39 for January-March 2022 as against Tk. 0.50 for January-March 2021. NOCFPS was Tk. 1.33
(Q1 Un-audited): EPS was Tk. 0.39 for January-March 2022 as against Tk. 0.50 for January-March 2021. NOCFPS was Tk. 1.33 for January-March 2022 as against Tk. 0.96 for January-March 2021. NAV per share was Tk. 18.30 as on March 31, 2022 and Tk. 17.53 as on December 31, 2021. Reason for Significant deviation in EPS, NOCFPS and NAV: EPS has been decreased due to decrease in investment and other income and increasing management expenses, re-insurance expenses (cont.)
- Q1 Financials
(Continuation news of CITYGENINS): and claim expenses. NOCFPS has been increased due to increase in company?s premium income. NAV has been increased due to increase in company?s investments in share and FDR. (End)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the company has informed that a meeting of the Board of Directors will be held on April 25, 2022 at 2:15 PM to consider, among others, un-audited financial statements of the company for the First Quarter (Q1) period ended March 31, 2022.
- Update of Information
The Company has requested the concerned Brokerage Houses/DPs to provide the statement both hard and soft copy to [email protected] with details of their margin loan holders entitled to Final Dividend 2021 on or before April 12, 2022. The statement should include Shareholder's name, BOID Number, e-mail, client-wise shareholding position, contact person etc. The record date was March 22, 2022.
- Resumption after record date
Trading of the shares of the Company will resume on 23.03.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 22.03.2022.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 20.03.2022 to 21.03.2022. Trading of the shares of the Company will remain suspended on record date i.e., 22.03.2022.
- The Board of Directors has recommended 10\% cash dividend for the year ended December 31, 2021. Date of AGM: 25.04.2022,
The Board of Directors has recommended 10\% cash dividend for the year ended December 31, 2021. Date of AGM: 25.04.2022, Time: 11:00 AM, Venue: Digital Platform. Record Date: 22.03.2022. The Company has also reported EPS of Tk. 1.68, NAV per share of Tk. 17.53 and NOCFPS of Tk. 2.75 for the year ended December 31, 2021 as against Tk. 1.77, Tk. 16.88 and Tk. 1.69 respectively for the same period of the previous year. (cont.1)
- (Continuation news of CITYGENINS): Reason for significant deviation in EPS, NOCFPS and NAV per share: EPS has been decre
(Continuation news of CITYGENINS): Reason for significant deviation in EPS, NOCFPS and NAV per share: EPS has been decreased for the year ended December 31, 2021 comparison with the previous year because of un-realized loss on share increased of re-insurance expenses and claim expenses. NOCFPS: NOCFPS has been increased for the year ended December 31, 2021 comparison with the previous year due to increase of premium income. (cont.2)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (01.03.2022) following its corporate declaration.
- Dividend Declaration
(Continuation news of CITYGENINS): Net Assets Value per share: NAV has been increased for the year ended December 31, 2021 comparison with the previous year due to increase of investment in share, Govt. Treasury Bond and FDR. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 28, 2022 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2021.
- Credit Rating Information and Services Limited (CRISL) has assigned the CPA (Claim Paying Ability) Rating of the Company
Credit Rating Information and Services Limited (CRISL) has assigned the CPA (Claim Paying Ability) Rating of the Company \"AA-\" along with a stable outlook in consideration of audited financial statements of the Company up to December 31, 2020; unaudited financials up to September 30, 2021 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- The Credit Rating Information and Services Limited (CRISL) has further informed that assigned the CPA (Claim Paying Abil
The Credit Rating Information and Services Limited (CRISL) has further informed that assigned the CPA (Claim Paying Ability) Rating of the Company \"AA\" instead of \"AA-\" along with a stable outlook in consideration of audited financial statements of the Company up to December 31, 2020.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.